- 现金
- 3700 元
- 精华
- 16
- 帖子
- 1790
- 注册时间
- 2002-12-9
- 最后登录
- 2021-4-14
|
1楼
发表于 2004-8-11 00:47
Mechanisms OF Chronic HBV Infection
Defective dendritic cell (DC)-T cell interaction. A defect in T cell immunity has been assumed to be central to persistent HBV infection. Recent studies in transgenic mice have suggested that a functional defect of DCs is an underlying cause of T cell dysfunction. More recently, BJ Zheng and others studied monocyte-derived DCs and T cells generated from peripheral blood mononuclear cells obtained from the following groups of patients: (1) chronic HBV patients with low HBV load, (2) chronic HBV patients with high HBV load, (3) anti-HBs-positive subjects who had recovered from acute HBV infection, (4) healthy donors who had received HBV vaccination and were anti-HBs-positive, and (5) subjects who were immunologically naive to HBV exposure or vaccination. The following DC-T cell interaction dysfunctions were observed: (1) failure of DCs to increase expression of HLA-II and B7 in response to HBsAg, (2) failure of DCs to increase IL-12 secretion in response to HBsAg, (3) defective induction of T cell proliferation in response to HBsAg, (4) failure to activate T cells to produce cytokines, and (5) defect in induction of antigen-specific cytotoxic T lymphocytes. These defects were especially prominent in patients with active HBV replication. The authors found that the functional impairment in DC-T cell interaction was improved by in vitro DC exposure to TNF-a. These data suggest that defective DC-T cell interaction may play a crucial role in the mechanism of chronic HBV infection. Immunotherapy that reverses or improves the impaired function of DC-T cell interactions may be a potentially useful treatment for patients with chronic HBV infection. (Zheng BJ et al. J Viral Hepat 2004;11: 217-224.)
|
|